▲ Up
 
06:28 27-02-2015
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug maker Shire rejects offer from AbbVie worth $46 billion

Bishkek (AKIpress) - drugs The Irish pharmaceutical company Shire said on Friday that it had rejected a takeover approach from the American drug maker AbbVie that valued the company at 27.2 billion pounds, or about $46.3 billion, the NY Times said. 

AbbVie, which is based in Chicago, revealed on Friday that it had first approached Shire in early May about a possible tie-up, but was rejected three times by Shire’s board of directors – the latest at the end of May. AbbVie was spun off from Abbott Laboratories last year.

Shire called AbbVie’s proposal “unsolicited and highly conditional” and said that it “fundamentally undervalued the company and its prospects.”

“We believe that Shire has a strong independent future,” Susan Kilsby, the Shire chairwoman, said in a statement.

Under British takeover rules, AbbVie has until July 18 to make a firm offer for Shire or walk away for at least six months before coming back with a further unsolicited offer. After three months, it is possible for the sides to reengage if Shire’s board agrees to it.

“There can be no certainty that any firm offer will be made,” AbbVie said in a statement. “Discussions are no longer ongoing.”

The latest cash and share offer was equal to £46.26 a share, AbbVie said.

Shire’s shares rose 13 percent to £42.26 in trading in London on Friday morning.


Twitterfacebookprint
16:29 20.06.2014
LATEST NEWS
17:35 Almazbek Atambayev: Who else do Bakiyevs have to kill for Belarusian authorities finally to see their bestial, cannibalistic nature?17:30 Uzbek boxer Ruslan Chagaev to fight for WBA title against Australian Lucas Browne17:18 President passes amendments to law on protection of consumers rights17:09 Member of banned movement Group 24 arrested in Finland16:51 Parliament ratifies €38 million grant agreement with Germany16:38 Tashkent internet cafes closed by 9pm to protect youth16:33 Tougher Internet rules to hit cable, telecoms companies16:24 Turkmen President, Kyrgyz FM discuss issues of bilateral cooperation16:21 Air strike kills 17 Islamic State militants, nine civilians in Iraq16:17 Government seeks assistance from FAO to strengthen national capacity for monitoring country's forests16:14 Kaz Minerals revenues go 9% down in 201416:06 Kaz Minerals produces 84k tons of copper cathode16:03 Kyrgyz Ministry of Defence awards 11 people with Namys medal for Kurmanjan Datka film15:56 Prostitution brothel found in Osh; administrator released on bail15:40 Ata Meken sends letter to Prosecutor General upon legality of 12 pines transplantation in Oak Park15:37 KAZ Minerals PLC appoints independent non-executive director15:28 Volume of water in Toktogul decreases by 30.70%15:23 Qatar delegation to get acquainted with Kyrgyz hospitals' needs15:17 Government to establish state agency to control alcohol industry in Kyrgyzstan15:11 30yo man committs suicide allegedly due to failed marriage
Astana
-3° C
Ashgabat
+5° C
Bishkek
+2° C
Dushanbe
0° C
Tashkent
+6° C
exchange rates
 
69.58
61.16
9.78
0.98
210.48
185.05
29.56
2.96
6.21
5.46
0.87
0.09
2774.81
2448.16
391.76
37.07
3.98
3.50
0.56
0.06

© AKIpress News Agency - 2001-2015. All rights reserved
Republication of any material is prohibited without a written agreement with AKIpress News Agency. Any citation must be accompanied by a hyperlink to www.akipress.com.
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75